Zdrowie i gospodarka · 03/03/2015
FDA Announces Public Workshop on Pediatric Neurocognitive Therapeutics
The FDA is hosting a 2-day public workshop to discuss advancing pediatric regulatory science and neurocognitive outcomes in pediatric patients, with a focus on developing pediatric therapeutics.
Source: Federal Register — Food and Drug AdministrationOpen original release →